---
figid: PMC9281252__12032_2022_1749_Fig1_HTML
figtitle: 'Molecular perspective on targeted therapy in breast cancer: a review of
  current status'
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9281252
filename: 12032_2022_1749_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9281252/figure/Fig1/
number: F1
caption: Trastuzumab and pertuzumab inhibit HER2 signaling by binding to the extracellular
  domain of HER2. Lapatinib, neratinib, tucatinib, and pyrotinib inhibit HER signaling
  by binding to the intracellular tyrosine kinase domain of the Her family members.
  EGFR epidermal growth factor receptor, HER human epidermal growth factor receptor,
  MEK MAP kinase kinase, ERK MAP kinase, PI3K phosphoinositide 3-kinases (adapted
  from “HER2 Signaling Pathway”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)
papertitle: 'Molecular perspective on targeted therapy in breast cancer: a review
  of current status.'
reftext: Busra Demir Cetinkaya, et al. Med Oncol. 2022;39(10):149.
year: '2022'
doi: 10.1007/s12032-022-01749-1
journal_title: Medical Oncology (Northwood, London, England)
journal_nlm_ta: Med Oncol
publisher_name: Springer US
keywords: Breast cancer | Targeted therapy | PI3K/Akt/mTOR pathway inhibitors | CDK4/6
  inhibitors | PARP inhibitors
automl_pathway: 0.9638411
figid_alias: PMC9281252__F1
figtype: Figure
redirect_from: /figures/PMC9281252__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9281252__12032_2022_1749_Fig1_HTML.html
  '@type': Dataset
  description: Trastuzumab and pertuzumab inhibit HER2 signaling by binding to the
    extracellular domain of HER2. Lapatinib, neratinib, tucatinib, and pyrotinib inhibit
    HER signaling by binding to the intracellular tyrosine kinase domain of the Her
    family members. EGFR epidermal growth factor receptor, HER human epidermal growth
    factor receptor, MEK MAP kinase kinase, ERK MAP kinase, PI3K phosphoinositide
    3-kinases (adapted from “HER2 Signaling Pathway”, by BioRender.com (2022). Retrieved
    from https://app.biorender.com/biorender-templates)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB2
  - ERBB3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - ERBB4
  - Egfr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - her
  - Hesr
---
